Advertisement
Screener

LIFE TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options, 2012

LIFE TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2012-12-27: Reporting owner LUCIER GREGORY T; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2012-12-26: Reporting owner LUCIER GREGORY T; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2012-12-11: Reporting owner LORIMIER BRADLEY G; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2012-10-15: Reporting owner LEVINE ARNOLD J; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2012-12-27LUCIER GREGORY T
Officer (Chief Executive Officer)
4Stock Options
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−150,655
0 owned after
$19.01
exercise price
2012-12-28
2012-12-26LUCIER GREGORY T
Officer (Chief Executive Officer)
4Stock Options
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−356,697
150,655 owned after
$19.01
exercise price
2012-12-28
2012-12-11LORIMIER BRADLEY G
Director
4Stock Options
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−20,000
0 owned after
$15.04
exercise price
2012-12-12
2012-10-15LEVINE ARNOLD J
Director
4Stock Options
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−6,958
0 owned after
$23.00
exercise price
2012-10-16
2012-05-01LORIMIER BRADLEY G
Director
4Stock Options
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−20,000
0 owned after
$17.56
exercise price
2012-05-03
2012-04-02Stevenson Mark
Officer (President & COO)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+72,901
72,901 owned after
$48.91
exercise price
2012-04-04
2012-04-02RICHARD KELLI
Officer (Chief Accounting Officer)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,668
10,668 owned after
$48.91
exercise price
2012-04-04
2012-04-02LUCIER GREGORY T
Officer (Chief Executive Officer)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+160,028
160,028 owned after
$48.91
exercise price
2012-04-04
2012-04-02Leddy Peter Michael
Officer (SVP, Global Human Resources)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+21,337
21,337 owned after
$48.91
exercise price
2012-04-04
2012-04-02Hoffmeister David F
Officer (Chief Financial Officer)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+35,561
35,561 owned after
$48.91
exercise price
2012-04-04
2012-04-02COTTINGHAM JOHN A
Officer (Chief Legal Officer)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+21,337
21,337 owned after
$48.91
exercise price
2012-04-04
2012-04-02ANDREWS RONALD ASBURY
Officer (President, Medical Sciences)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+21,337
21,337 owned after
$48.91
exercise price
2012-04-04
2012-02-02
holding as of filing
ANDREWS RONALD ASBURY
Officer (President, Medical Sciences)
3Stock Options
Derivative · Direct
Holding$48.99
exercise price
2012-02-02
2012-01-25DITTAMORE RAYMOND V
Director
4Stock Options
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−20,000
0 owned after
$17.56
exercise price
2012-01-26